Abstract
Esthesioneuroblastomas are uncommon tumors in pediatric patients and are typically treated with multimodal therapy. Changes in gross tumor quality and character in response to adjuvant treatment have not been clearly reported. We report the case of a 15-year-old female with a diagnosis of Kadish stage C esthesioneuroblastoma who was treated with neoadjuvant chemotherapy and surgical resection. The patient’s tumor demonstrated cytoreduction after chemotherapy but also was found to have calcified. A combined trans-frontal sinus craniotomy with endoscopic endonasal resection was performed and resulted in negative margins and good clinical outcome.
Similar content being viewed by others
References
Bisogno G, Soloni P, Conte M, Podda M, Ferrari A, Garaventa A, Luksch R, Cecchetto G (2012) Esthesioneuroblastoma in pediatric and adolescent age. A report from the TREP project in cooperation with the Italian Neuroblastoma and Soft Tissue Sarcoma Committees. BMC Cancer 12:117
Benoit MM, Bhattacharyya N, Faquin W, Cunningham M (2008) Cancer of the nasal cavity in the pediatric population. Pediatrics 121:e141–e145
Elkon D, Hightower SI, Lim ML, Cantrell RW, Constable WC (1979) Esthesioneuroblastoma. Cancer 44:1087–1094
Venkatramani R, Pan H, Furman WL, Marron JM, Haduong J, Friedrich-Medina P, Mahajan A, Bavle A, Wu H, Chintagumpala M (2016) Multimodality treatment of pediatric esthesioneuroblastoma. Pediatr Blood Cancer 63:465–470
El Kababri M, Habrand JL, Valteau-Couanet D, Gaspar N, Dufour C, Oberlin O (2014) Esthesioneuroblastoma in children and adolescent: experience on 11 cases with literature review. J Pediatr Hematol Oncol 36:91–95
Modesto A, Blanchard P, Tao YG, Rives M, Janot F, Serrano E, Benlyazid A, Guigay J, Ferrand FR, Delord JP, Bourhis J, Daly-Schveitzer N (2013) Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma. Oral Oncol 49:830–834
Platek ME, Merzianu M, Mashtare TL, Popat SR, Rigual NR, Warren GW, Singh AK (2011) Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database. Radiat Oncol 6:41
Cunningham MJ, Lin DT, Curry WT, Ebb DH, Yock TI, Curtin HD, Faquin WC (2007) An 11-year-old boy with a calcified mass in the nose. N Engl J Med 356:2721–2730
Sarper N, Corapçioğlu F, Anik Y, Ural D, Yildiz K, Tugay M (2006) Unresectable multifocal hepatoblastoma with cardiac extension: excellent response with HB-94 chemotherapy protocol. J Pediatr Hematol Oncol 28:386–390
Shields CL, Palamar M, Sharma P, Ramasubramanian A, Leahey A, Meadows AT, Shields JA (2009) Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors. Arch Ophthalmol 127:282–290
Kogachi K, Kim JW, Green S, Jubran R, Berry JL (2018) Lurking below: massive choroidal invasion under a calcified tumor after attempted conservative therapy for retinoblastoma. Ophthalmic Genet 39:653–657
Gallagher KK, Spector ME, Pepper J-P, McKean EL, Marentette LJ, McHugh JB (2014) Esthesioneuroblastoma: updating histologic grading as it relates to prognosis. Ann Otol Rhinol Laryngol 123:353–358
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Michael McDowell, none. Souvik Roy, none. Ezequiel Goldschmidt, none. Paul Gardner, consultant/ownership interest for SPIWay, LLC and consultant for Stryker. Elizabeth Tyler-Kabara, none. Carl Snyderman, consultant/ownership interest for SPIWay, LLC.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(PNG 144 mb)
Rights and permissions
About this article
Cite this article
McDowell, M.M., Roy, S., Goldschmidt, E. et al. Extensive tumor calcification in response to pre-operative reductive chemotherapy in pediatric esthesioneuroblastoma: a case report. Childs Nerv Syst 36, 2099–2102 (2020). https://doi.org/10.1007/s00381-020-04545-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-020-04545-2